- Report
- June 2023
- 200 Pages
Global
From €4818EUR$4,850USD£4,006GBP
- Report
- June 2022
- 138 Pages
Global
From €3825EUR$3,850USD£3,180GBP
- Report
- April 2022
- 230 Pages
Global
From €4818EUR$4,850USD£4,006GBP
- Report
- April 2022
- 120 Pages
Global
From €3825EUR$3,850USD£3,180GBP
- Report
- April 2022
- 250 Pages
Global
From €6805EUR$6,850USD£5,658GBP
- Report
- January 2022
- 125 Pages
Global
€3825EUR$3,850USD£3,180GBP
- Report
- January 2022
- 100 Pages
Global
€3825EUR$3,850USD£3,180GBP
- Report
- September 2021
- 100 Pages
Global
€3825EUR$3,850USD£3,180GBP
- Report
- May 2022
- 217 Pages
Asia Pacific
From €2931EUR$2,950USD£2,437GBP
- Report
- May 2022
- 188 Pages
Global
From €5514EUR$5,550USD£4,584GBP
- Report
- September 2023
- 100 Pages
United States
From €5911EUR$5,950USD£4,915GBP
- Report
- January 2023
- 100 Pages
Global
From €5911EUR$5,950USD£4,915GBP
- Report
- January 2023
- 95 Pages
Latin America
From €3924EUR$3,950USD£3,263GBP
- Report
- April 2022
- 120 Pages
Global
From €5911EUR$5,950USD£4,915GBP
- Report
- February 2019
- 148 Pages
Global
From €2903EUR$2,923USD£2,414GBP
€4148EUR$4,175USD£3,449GBP
- Report
- February 2023
- 155 Pages
Global
From €2474EUR$2,490USD£2,057GBP
- Report
- November 2022
- 150 Pages
United States
From €2474EUR$2,490USD£2,057GBP
- Report
- October 2022
- 165 Pages
Global
From €2176EUR$2,190USD£1,809GBP
- Report
- April 2022
- 73 Pages
United States
From €2235EUR$2,250USD£1,859GBP
- Report
- June 2021
- 104 Pages
Global
From €944EUR$950USD£785GBP
The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more